New pill could let sunlight-sensitive patients enjoy the sun longer without burning pain
Symptom relief
Ongoing
This study tests an experimental drug called MT-7117 in 165 people aged 12 to 75 who have erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), conditions that cause severe pain from sunlight exposure. Participants are randomly assigned to receive either the drug …
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC